Article
Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment.
Haemophilia : the official journal of the World Federation of Hemophilia - 1 Nov 2008
Meeks S L, Abshire T C
Abstract excerpt
Prothrombin (factor II) deficiency is a rare autosomal recessive coagulation disorder that occurs in approximately 1 in 1-2 million people. Prothrombin is activated to thrombin, which in turn proteolytically cleaves fibrinogen to fibrin and contributes to forming a stable fibrin clot. The haemostatic level of prothrombin is thought to be between 20 and 40%, and the half-life is approximately 3 days. There are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
